Julien Mancini
About Julien Mancini
Julien Mancini is a professor at Aix-Marseille University, specializing in cancer, biomedicine, and public health. He has extensive experience in clinical epidemiology and biostatistics, with a focus on the psychosocial impact of cancer, particularly regarding fertility and parenthood issues.
Current Position at Aix-Marseille University
Julien Mancini serves as a Professor (PU-PH) at Aix-Marseille University since 2019. He is affiliated with the Cancer, Biomedicine & Society group within the UMR1252 SESSTIM research unit. His role involves teaching courses in epidemiology and biostatistics, contributing to the academic development of students in these fields.
Professional Experience at APHM
Julien Mancini has been a Hospital Practitioner (MCU-PH) at Assistance Publique - Hôpitaux de Marseille (APHM) since 2010. He works in the Clinical Epidemiology & Biostatistics Unit (BIOSTIC) within the Public Health Department. His current role has been ongoing for over 14 years, focusing on clinical epidemiology and biostatistics.
Educational Background and Qualifications
Julien Mancini studied at Aix-Marseille Université, where he achieved his Doctor of Medicine (M.D.) from 1994 to 2006. He also completed a Doctor of Philosophy (Ph.D.) in Oncology from 2005 to 2008. Additionally, he obtained a Master’s Degree in Public Health, Epidemiology (MPH) from Université Paris Sud (Paris XI) in 2004. He achieved Habilitation à Diriger des Recherches (HDR) from 2015 to 2016.
Research Focus and Contributions
Julien Mancini's research primarily addresses the psychosocial impact of cancer, particularly concerning fertility and parenthood issues. He engages in studies related to cancer patient autonomy in decision-making, including their participation in clinical trials and biobanks. He has been involved in developing standardized information documents for cancer patients.
Previous Research Roles
Julien Mancini has held visiting researcher positions at notable institutions. He worked at the University of Sydney's Centre for Medical Psychology & Evidence-based Decision-making (CeMPED) for five months in 2013. In 2016, he was a visiting researcher at Memorial Sloan Kettering Cancer Center in the Center for Health Policy and Outcomes, also for five months.